Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Levy

Showing results (61-70 of 1,534) with videos related to

Pageof 154
Sort By:
The New England Journal of Medicine|November 19, 2004
C/EBPalpha in asthmaDaniel I Levy
The American Journal of Cardiology|August 27, 1984
Causes of the decrease in cardiovascular mortalityR I Levy
Clinical Research|March 12, 1982
Clinical trials: are the benefits worth the costs?R I Levy
Preventive Medicine|December 1, 1978
Progress in prevention of cardiovascular diseaseR I Levy
The New England Journal of Medicine|March 1, 1979
Stroke decline: implications and prospectsR I Levy
Federation Proceedings|May 1, 1971
Classification and etiology of hyperlipoproteinemiasR I Levy
The American Journal of Cardiology|May 30, 1986
Changing perspectives in the prevention of coronary artery diseaseR I Levy
Modern Concepts of Cardiovascular Disease|October 1, 1978
Progress toward prevention of cardiovascular disease: a thirty-year retrospectiveR I Levy
Clinical Chemistry|May 1, 1981
Cholesterol, lipoproteins, apoproteins, and heart disease: present status and future prospectsR I Levy
Hypertension (Dallas, Tex. : 1979)|March 2, 2005
Beneficial effects of circulating progenitor endothelial cells activated by angiotensin receptor antagonistsBernard I Levy
Pageof 154

Showing results (61-70 of 1,534) with videos related to

Sort By:
Pageof 154
The New England Journal of Medicine|November 19, 2004
C/EBPalpha in asthmaDaniel I Levy
The American Journal of Cardiology|August 27, 1984
Causes of the decrease in cardiovascular mortalityR I Levy
Clinical Research|March 12, 1982
Clinical trials: are the benefits worth the costs?R I Levy
Preventive Medicine|December 1, 1978
Progress in prevention of cardiovascular diseaseR I Levy
The New England Journal of Medicine|March 1, 1979
Stroke decline: implications and prospectsR I Levy
Federation Proceedings|May 1, 1971
Classification and etiology of hyperlipoproteinemiasR I Levy
The American Journal of Cardiology|May 30, 1986
Changing perspectives in the prevention of coronary artery diseaseR I Levy
Modern Concepts of Cardiovascular Disease|October 1, 1978
Progress toward prevention of cardiovascular disease: a thirty-year retrospectiveR I Levy
Clinical Chemistry|May 1, 1981
Cholesterol, lipoproteins, apoproteins, and heart disease: present status and future prospectsR I Levy
Hypertension (Dallas, Tex. : 1979)|March 2, 2005
Beneficial effects of circulating progenitor endothelial cells activated by angiotensin receptor antagonistsBernard I Levy
Pageof 154